Emerging therapies for small cell lung cancer

Currently, chemotherapy remains the standard treatment for first- and second-line management of small cell lung cancer (SCLC). Immunotherapy has made progress in the treatment of SCLC, and nivolumab, pembroliz...

Source: Journal of Hematology and Oncology - May 2, 2019 Category: Hematology Authors: Sen Yang, Zhe Zhang and Qiming Wang Tags: Review Source Type: research